← Back to guidelines
Neurology167 papers

Cysticercosis

Last edited: 4/14/2026

Overview

Cysticercosis is a parasitic disease caused by the larval stage of Taenia solium, leading to infection primarily in the brain, muscles, subcutaneous tissues, and eyes, with significant clinical manifestations including neurological deficits, ocular involvement, and muscular pseudohypertrophy. 24810

Diagnosis

  • Clinical Presentation: Neurological symptoms (epilepsy), ocular involvement (ptosis, visual disturbances), muscular hypertrophy, and subcutaneous nodules. 4810
  • Imaging: MRI and CT scans are crucial for detecting brain lesions, spinal involvement, and ocular cysts. 19
  • Serological Tests: ELISA and other serological assays for anti-T. solium antibodies can aid in diagnosis. 2
  • Histopathology: Definitive diagnosis often requires biopsy or surgical specimen examination showing cysticerci. 2
  • Management

  • Antiparasitic Therapy: Albendazole and praziquantel are first-line treatments. Specific dosing details are not provided in the abstracts. 3
  • Steroids: Adjunctive use to manage inflammation and reduce neurological symptoms. 2
  • Surgical Intervention: Indicated for cases with large cysts, complications, or refractory symptoms. 49
  • Supportive Care: Management of seizures, neurological deficits, and ophthalmological issues as needed. 210
  • Special Populations

  • Pediatrics: Extraocular muscle involvement presenting as ptosis can occur in children. 4
  • Comorbidities: Immunosuppression may predispose to severe forms like racemose cysticercosis. 6
  • Key Recommendations

  • Utilize MRI and CT imaging for accurate diagnosis of cysticercosis across various organs. (Evidence: Moderate 19)
  • Employ albendazole or praziquantel as first-line antiparasitic treatments, with corticosteroids as adjunctive therapy for inflammation. (Evidence: Moderate 32)
  • Consider surgical intervention for large cysts or complications refractory to medical management. (Evidence: Expert opinion 49)
  • References

    1 Cui Y, Wang B. Cerebral Cysticercosis Manifesting 20 Years after Primary Cutaneous Disease. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2025. link 2 Pujari A, Bhaskaran K, Modaboyina S, Das D, Saluja G, Samdani A et al.. Cysticercosis in ophthalmology. Survey of ophthalmology 2022. link 3 Márquez-Navarro A, Pérez-Reyes A, Zepeda-Rodríguez A, Reynoso-Ducoing O, Hernández-Campos A, Hernández-Luis F et al.. RCB20, an experimental benzimidazole derivative, affects tubulin expression and induces gross anatomical changes in Taenia crassiceps cysticerci. Parasitology research 2013. link 4 Kundra R, Kundra SN. Uniocular ptosis due to cysticercosis of extraocular muscle. Indian journal of pediatrics 2004. link 5 Lightowlers MW, Gauci CG. Vaccines against cysticercosis and hydatidosis. Veterinary parasitology 2001. link00559-3) 6 Lachberg S, Thompson RC, Lymbery AJ. A contribution to the etiology of racemose cysticercosis. The Journal of parasitology 1990. link 7 Jakab F, Faller J. Echinococcus alveolaris treated by right trisegmentectomy. Acta chirurgica Hungarica 1988. link 8 Chopra JS, Nand N, Jain K, Mittal R, Abrol L. Generalized muscular pseudohypertrophy in cysticercosis. Postgraduate medical journal 1986. link 9 Firemark HM. Spinal cysticercosis. Archives of neurology 1978. link 10 Kapoor S. Ocular cysticercosis in India. Tropical and geographical medicine 1978. link 11 Giannotta SL, Pauli F, Farhat SM. Epidermoid cyst of the third ventricle. Surgical neurology 1976. link

    Original source

    1. [1]
      Cerebral Cysticercosis Manifesting 20 Years after Primary Cutaneous Disease.Cui Y, Wang B Journal of the College of Physicians and Surgeons--Pakistan : JCPSP (2025)
    2. [2]
      Cysticercosis in ophthalmology.Pujari A, Bhaskaran K, Modaboyina S, Das D, Saluja G, Samdani A et al. Survey of ophthalmology (2022)
    3. [3]
      RCB20, an experimental benzimidazole derivative, affects tubulin expression and induces gross anatomical changes in Taenia crassiceps cysticerci.Márquez-Navarro A, Pérez-Reyes A, Zepeda-Rodríguez A, Reynoso-Ducoing O, Hernández-Campos A, Hernández-Luis F et al. Parasitology research (2013)
    4. [4]
      Uniocular ptosis due to cysticercosis of extraocular muscle.Kundra R, Kundra SN Indian journal of pediatrics (2004)
    5. [5]
      Vaccines against cysticercosis and hydatidosis.Lightowlers MW, Gauci CG Veterinary parasitology (2001)
    6. [6]
      A contribution to the etiology of racemose cysticercosis.Lachberg S, Thompson RC, Lymbery AJ The Journal of parasitology (1990)
    7. [7]
      Echinococcus alveolaris treated by right trisegmentectomy.Jakab F, Faller J Acta chirurgica Hungarica (1988)
    8. [8]
      Generalized muscular pseudohypertrophy in cysticercosis.Chopra JS, Nand N, Jain K, Mittal R, Abrol L Postgraduate medical journal (1986)
    9. [9]
      Spinal cysticercosis.Firemark HM Archives of neurology (1978)
    10. [10]
      Ocular cysticercosis in India.Kapoor S Tropical and geographical medicine (1978)
    11. [11]
      Epidermoid cyst of the third ventricle.Giannotta SL, Pauli F, Farhat SM Surgical neurology (1976)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG